Fennec Pharmaceuticals (FENC) Asset Utilization Ratio (2020 - 2025)

Fennec Pharmaceuticals' Asset Utilization Ratio history runs 5 years deep, the most recent figure standing at 0.75 for Q4 2025.

• Quarterly Asset Utilization Ratio fell 18.59% year-over-year to 0.75 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.75 (down 18.59% YoY) and the FY2025 annual result came in at 0.77, down 41.61% from the prior year.
• Asset Utilization Ratio was 0.75 for Q4 2025 at Fennec Pharmaceuticals, down from 0.82 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.94 in Q1 2024 and bottomed at 0.01 in Q1 2021.
• A 4-year average of 0.63 and a median of 0.74 in 2024 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2024 — Asset Utilization Ratio jumped 1115.68% — and 2025, when it declined 27.69%.
• Fennec Pharmaceuticals' Asset Utilization Ratio stood at 0.01 in 2021, then jumped by 13338.91% to 0.91 in 2023, then advanced by 0.88% to 0.92 in 2024, then fell by 18.59% to 0.75 in 2025.
• Business Quant data shows FENC's Asset Utilization Ratio at 0.75 in Q4 2025, 0.82 in Q3 2025, and 0.73 in Q2 2025.